Literature DB >> 12540334

Prevalence of overactive bladder and urinary incontinence.

Fabio Parazzini1, Maurizio Lavezzari, Walter Arbitani.   

Abstract

We conducted a cross-sectional study in Italy among men at least 50 years old and women at least 40 years old who consecutively visited their general practitioners. Patients were asked about the frequency of symptoms of overactive bladder and urinary incontinence. A total of 9613 men (mean age, 64.8 years; range, 50-98 years) and 13,365 women (mean age, 60.3 years; range, 40-98 years) were identified by 774 general practitioners. The frequencies of overactive bladder were 3.0% (95% confidence interval, 2.7-3.5) in men and 1.1% (95% confidence interval, 0.9-1.3) in women. The corresponding frequencies for urinary incontinence were 8.3% (95% confidence interval, 7.7-8.9) in men and 10.2% (95% confidence interval, 9.6-10.8) in women.

Entities:  

Mesh:

Year:  2002        PMID: 12540334

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  3 in total

1.  A population-based survey of lower urinary tract symptoms (LUTS) and symptom-specific bother: results from the Brazilian LUTS epidemiology study (BLUES).

Authors:  Edson D Moreira; Raimundo C S Neves; Antônio Fernandes Neto; Fernanda G Duarte; Teresinha L Moreira; Carlos F L Lobo; Dale B Glasser
Journal:  World J Urol       Date:  2013-03-21       Impact factor: 4.226

2.  Is the prevalence of overactive bladder overestimated? A population-based study in Finland.

Authors:  Kari A O Tikkinen; Teuvo L J Tammela; Aila M Rissanen; Antti Valpas; Heini Huhtala; Anssi Auvinen
Journal:  PLoS One       Date:  2007-02-07       Impact factor: 3.240

3.  Assessment of Proportion of Hidden Patients Having Symptoms of Overactive Bladder and Why Has It Been Hidden in Female Outpatients Admitted to Hospital.

Authors:  Oktay Üçer; Ömer Demir; Mehmet Fatih Zeren; Yasin Ceylan; İlker Çelen; Ali Ersin Zümrütbaş; Gökhan Temeltaş; Ozan Bozkurt; Bülent Günlüsoy; Orçun Çelik; Gökhan Ekin; Oğuz Mertoğlu
Journal:  Int Neurourol J       Date:  2016-03-07       Impact factor: 2.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.